1. Academic Validation
  2. Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists

Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists

  • Bioorg Med Chem Lett. 2006 Jan 1;16(1):200-3. doi: 10.1016/j.bmcl.2005.09.020.
Andrew G Cole 1 Ilana L Stroke Marc-Raleigh Brescia Srilatha Simhadri Joan J Zhang Zahid Hussain Michael Snider Christopher Haskell Sofia Ribeiro Kenneth C Appell Ian Henderson Maria L Webb
Affiliations

Affiliation

  • 1 Pharmacopeia Drug Discovery, Inc., PO Box 5350, Princeton, NJ 08543, USA. acole@pcop.com
Abstract

The identification and evaluation of aryl-[1,4]diazepane ureas as functional antagonists of the Chemokine Receptor CXCR3 are described. Specific examples exhibit IC(50) values of approximately 60 nM in a calcium mobilization functional assay, and dose-dependently inhibit CXCR3 functional response to CXCL11 (interferon-inducible T-cell alpha chemoattractant/I-TAC) as measured by T-cell chemotaxis, with a potency of approximately 100 nM.

Figures